How white is your smile?

Trellus Management Company LLC cut its stake in Biolase (NASDAQ:BIOL) by 35.0% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 375,028 shares of the medical technology company’s stock after selling 202,326 shares …

See the full post >